Ascentage Pharma Group International (NASDAQ:AAPG) Stock Rated Market Outperform in New Coverage at Citizens Jmp

Citizens Jmp began coverage on shares of Ascentage Pharma Group International (NASDAQ:AAPG) in a research note issued to investors on Tuesday morning, MarketBeat.com reports. The brokerage issued a market outperform rating and a $35.00 price objective on the stock.

Several other research firms also recently weighed in on AAPG. JPMorgan Chase & Co. reduced their target price on shares of Ascentage Pharma Group International from $46.00 to $33.00 and set an “overweight” rating for the company in a research note on Thursday, October 8th. Citigroup began coverage on shares of Ascentage Pharma Group International in a research note on Tuesday. They set a “buy” rating and a $46.00 price target on the stock. Finally, BTIG Research reiterated a “buy” rating and issued a $48.00 price objective on shares of Ascentage Pharma Group International in a research note on Friday, August 21st. Two research analysts have rated the stock with a Strong Buy rating and twelve have assigned a Buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $43.90.

Ascentage Pharma Group International Stock Down 1.1%

Shares of AAPG opened at $14.69 on Tuesday. Ascentage Pharma Group International has a 1 year low of $14.45 and a 1 year high of $37.50. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.18 and a current ratio of 1.22. The stock’s fifty day moving average price is $16.55 and its two-hundred day moving average price is $19.11.

Ascentage Pharma Group International (NASDAQ:AAPG) last posted its quarterly earnings results on Wednesday, August 19th. The company reported ($0.65) earnings per share for the quarter. The firm had revenue of $22.24 million during the quarter. As a group, equities research analysts anticipate that Ascentage Pharma Group International will post -2.42 earnings per share for the current year.

About Ascentage Pharma Group International

Ascentage Pharma Group International is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for cancer and other serious diseases.